Antidepressant drug alleviates hot flashes in men undergoing prostate cancer treatment

ROCHESTER, MINN. -- Venlafaxine, an antidepressant drug, helps reduce the incidence of hot flashes in men undergoing androgen-deprivation therapy for prostate cancer, according to a recent Mayo Clinic report published in the Journal of Urology.

The researchers found that 10 out of 16 men (63 percent), had a greater than 50 percent reduction in hot flashes at the end of the fourth week of taking the antidepressant drug compared to a baseline week in which study participants took no drugs for hot flashes. The incidence of severe and very severe hot flashes in each patient was reduced from an average of 2.3 per day during the baseline week to an average of less than one per day at the end of the study.

"Approximately three out of four men who undergo androgen-deprivation therapy experience uncomfortable hot flashes", says Charles L. Loprinzi, M.D., Mayo Clinic medical oncologist and one of the authors of the study.

Information from this pilot study suggests that antidepressants such as venlafaxine offer the first effective non-hormonal treatment for hot flashes in men. Ongoing work is looking at various doses of venlafaxine and similar antidepressants to better determine the efficiency and toxicity of this approach.


Contact: Mike O'Hara
507-284-9522 (days)
Mayo Clinic

Page: 1

Related medicine news :

1. Antidepressants may increase risk of abnormal bleeding
2. Antidepressant may help people stop smoking when used with nicotine patch
3. Antidepressants are not safe for children
4. Antidepressants decrease chronic pain by inhibiting TNF production in brain, UB researchers find
5. Antidepressant drugs may protect brain from damage due to depression
6. Antidepressant provides a cool choice for hot flashes
7. Antidepressants impair cognitive function in the elderly
8. Antidepressants Can Lead To Mouth Infections
9. UF Psychiatrists Use Antidepressants To Treat Smoking Addiction
10. Rape Victims Find Relief From Posttraumatic Stress Using The Antidepressant Zoloft.
11. Immersion in virtual world alleviates pain from injury

Post Your Comments:

(Date:11/24/2015)... ... , ... With Thanksgiving right around the corner, holiday travel season is about ... family and vehicle. , According to the National Highway Traffic Safety Administration, 301 people ... the following safety tips from the NHTSA: , ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Cleveland University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, a fifth-trimester student ... President Carl S. Cleveland III on October 16. , “Katie is very excited ...
(Date:11/24/2015)... ... November 24, 2015 , ... Bibliomotion is thrilled to ... Me about Reinvention and Diversity by Nancy M. Schlichting, Chief Executive Officer ... failing to adequately address the needs of patients and their families, shaped my desire ...
(Date:11/24/2015)... ... 2015 , ... All her life, Don Peck’s mother wondered if she was a descendant of ... been. After a 25-year search for information, Don and his aunt discovered that she ... name. Turns out, it was Don’s father who was descended from not one, but ...
(Date:11/24/2015)... ... 24, 2015 , ... GBCHealth and Global Health Council announced ... to the world’s best corporate-supported global health programs. The awards were presented ... held in Washington D.C and attended by over 150 representatives from the international ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... and BERN, Switzerland , November ... ARTORG Center for Biomedical Engineering Research of the University ... Division of Endocrinology, Diabetes and Clinical Nutrition of the ... start of an exclusive collaboration to develop a novel ... for the personalised delivery of insulin for diabetic patients ...
(Date:11/24/2015)... , November 24, 2015 st  Scientific ... North America (RSNA) taking place in Chicago ... Booth 1122, Hall A. --> st  Scientific Assembly and ... (RSNA) taking place in Chicago ... Hall A. --> Molecular Dynamics will present its revolutionary ...
(Date:11/24/2015)... The uptake of recently approved and pipeline premium products for Type 1 ... 2021, says GBI Research . --> ... Diabetes Mellitus (T1DM), will be a key driver of market growth to ... The uptake of recently approved and pipeline premium products for Type ... to 2021, says GBI Research . ...
Breaking Medicine Technology:
Cached News: